Astrocyte Pharmaceuticals Inc.
Cambridge, MA
- UEI
- ZEP1G3FGYUP3
- CAGE
- 79FT4
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 245 First St #1800, Cambridge, MA 02142, USA
- Website
- astrocytepharma.com
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Preclinical efficacy of AST-004 as a treatment for substance use disorder - project summary while overdoses and deaths… | National Institute on Drug Abuse | $399,680 | |
| Preclinical efficacy and safety evaluation of oral AST-004 for moderate traumatic brain injury (TBI) - project summary… | National Institute of Neurological Disorders and Stroke | $2,999,688 | |
| Astrocyte activation by small-molecule ADORA3 agonists: a novel therapy for alzheimer's disease | National Institute on Aging | $297,942 | |
| Preclinical development of AST-004 for astrocyte-mediated treatment of TBI. | National Institute of Neurological Disorders and Stroke | $2,995,803 | |
| Astrocyte activation by small molecule P2Y1 agonists for treatment of TBI | National Institute of Neurological Disorders and Stroke | $671,659 |
Quick answers
What is Astrocyte Pharmaceuticals Inc.'s UEI?
Astrocyte Pharmaceuticals Inc.'s Unique Entity ID (UEI) in SAM.gov is ZEP1G3FGYUP3.
What is Astrocyte Pharmaceuticals Inc.'s CAGE code?
Astrocyte Pharmaceuticals Inc.'s CAGE code is 79FT4.
Where is Astrocyte Pharmaceuticals Inc. located?
Astrocyte Pharmaceuticals Inc.'s physical address in SAM.gov is 245 First St #1800, Cambridge, MA 02142, USA.
Is Astrocyte Pharmaceuticals Inc. registered in SAM.gov?
Yes. Astrocyte Pharmaceuticals Inc.'s SAM.gov registration is active through June 24, 2027.
What is Astrocyte Pharmaceuticals Inc.'s most recent federal award?
Astrocyte Pharmaceuticals Inc.'s most recent federal grant award is Preclinical efficacy of AST-004 as a treatment for substance use disorder - project summary while overdoses and deaths… (R41DA064479), from National Institute on Drug Abuse, on July 15, 2026.
On GovTribe
See Astrocyte Pharmaceuticals Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors